FDA advises women with breast impants

The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic large cell lymphoma (ALC). The FDA adds that “the known ALCL cases are too few to say conclusively that breast implants cause the disease.” Read more at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm240985.htm and http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm241086.htm.